-
1
-
-
0037319024
-
Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS)
-
Sen S, Ratnaraj N, Davies NA et al: Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS). Epilepsia, 2003; 44: 265-67
-
(2003)
Epilepsia
, vol.44
, pp. 265-267
-
-
Sen, S.1
Ratnaraj, N.2
Davies, N.A.3
-
2
-
-
0020212849
-
Phenytoin overdose with high plasma levels (case report)
-
Subik M, Robinson DS: Phenytoin overdose with high plasma levels (case report). W V Med J, 1982; 78: 281-82
-
(1982)
W V Med J
, vol.78
, pp. 281-282
-
-
Subik, M.1
Robinson, D.S.2
-
3
-
-
33748561515
-
Hemodialysis and hemoperfusion in a patient with an isolated phenytoin overdose
-
Miller MA, Crystal CS, Patel MM: Hemodialysis and hemoperfusion in a patient with an isolated phenytoin overdose. Am J Emerg Med, 2006; 24: 748-49
-
(2006)
Am J Emerg Med
, vol.24
, pp. 748-749
-
-
Miller, M.A.1
Crystal, C.S.2
Patel, M.M.3
-
4
-
-
0017091574
-
Clinical pharmacokinetics of anticonvulsants
-
Hvidberg EF, Dam M: Clinical pharmacokinetics of anticonvulsants. Clin Pharmacokinet, 1976; 1: 161-88
-
(1976)
Clin Pharmacokinet
, vol.1
, pp. 161-188
-
-
Hvidberg, E.F.1
Dam, M.2
-
5
-
-
0017105967
-
Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy
-
Barth N, Alvan G, Borga O, Sjoqvist F: Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy. Clin Pharmacokinet, 1976; 1: 444-52
-
(1976)
Clin Pharmacokinet
, vol.1
, pp. 444-452
-
-
Barth, N.1
Alvan, G.2
Borga, O.3
Sjoqvist, F.4
-
6
-
-
0242543259
-
Clinical relevance of genetic polymorphisms in the human CYP2C9 gene
-
Schwarz UI: Clinical relevance of genetic polymorphisms in the human CYP2C9 gene. Eur J Clin Invest, 2003; 33(Suppl.2): 23-30
-
(2003)
Eur J Clin Invest
, vol.33
, Issue.SUPPL.2
, pp. 23-30
-
-
Schwarz, U.I.1
-
7
-
-
0034054661
-
Elimination of phenytoin in toxic overdose
-
Chua HC, Venketasubramanian N, Tjia H, Chan SP: Elimination of phenytoin in toxic overdose. Clin Neurol Neurosurg, 2000; 102: 6-8
-
(2000)
Clin Neurol Neurosurg
, vol.102
, pp. 6-8
-
-
Chua, H.C.1
Venketasubramanian, N.2
Tjia, H.3
Chan, S.P.4
-
8
-
-
0019819525
-
A prolonged severe intoxication after ingestion of phenytoin and phenobarbital
-
Albertson TE, Fisher CJ Jr, Shragg TA, Baselt RC: A prolonged severe intoxication after ingestion of phenytoin and phenobarbital. West J Med, 1981; 135: 418-22
-
(1981)
West J Med
, vol.135
, pp. 418-422
-
-
Albertson, T.E.1
Fisher Jr, C.J.2
Shragg, T.A.3
Baselt, R.C.4
-
9
-
-
0032853391
-
Differential kinetics of phenytoin in elderly patients
-
Bachmann KA, Belloto RJ Jr: Differential kinetics of phenytoin in elderly patients. Drugs Aging, 1999; 15: 235-50
-
(1999)
Drugs Aging
, vol.15
, pp. 235-250
-
-
Bachmann, K.A.1
Belloto Jr, R.J.2
-
10
-
-
0038196961
-
Clinically important drug interactions in epilepsy: General features and interactions between antiepileptic drugs
-
Patsalos PN, Perucca E: Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurology, 2003; 2: 347-56
-
(2003)
Lancet Neurology
, vol.2
, pp. 347-356
-
-
Patsalos, P.N.1
Perucca, E.2
-
11
-
-
0015692666
-
Pharmacokinetic consequences of plasma protein binding of drugs
-
Schoenemann PT, Yesair DW, Coffey JJ, Bullock FJ: Pharmacokinetic consequences of plasma protein binding of drugs. Ann NY Acad Sci, 1973; 226: 162-71
-
(1973)
Ann NY Acad Sci
, vol.226
, pp. 162-171
-
-
Schoenemann, P.T.1
Yesair, D.W.2
Coffey, J.J.3
Bullock, F.J.4
-
13
-
-
0031886117
-
Significant removal of phenytoin during high flux dialysis with cellulose triacetate dialyzer
-
Frenchie D, Bastani B: Significant removal of phenytoin during high flux dialysis with cellulose triacetate dialyzer. Nephrol Dial Transplant, 1998; 13: 817-18
-
(1998)
Nephrol Dial Transplant
, vol.13
, pp. 817-818
-
-
Frenchie, D.1
Bastani, B.2
-
14
-
-
0342656551
-
Cerebellar atrophy following acute phenytoin intoxication
-
Alioglu Z, Sari A, Velioglu SK et al: Cerebellar atrophy following acute phenytoin intoxication. J Neuroradiol, 2000; 27: 52-55
-
(2000)
J Neuroradiol
, vol.27
, pp. 52-55
-
-
Alioglu, Z.1
Sari, A.2
Velioglu, S.K.3
-
15
-
-
0033958641
-
Charcoal hemoperfusion in the treatment of phenytoin overdose
-
Kawasaki C, Nishi R, Uekihara S et al: Charcoal hemoperfusion in the treatment of phenytoin overdose. Am J Kidney Dis, 2000; 35: 323-26
-
(2000)
Am J Kidney Dis
, vol.35
, pp. 323-326
-
-
Kawasaki, C.1
Nishi, R.2
Uekihara, S.3
-
16
-
-
4143113422
-
Phenytoin overdose complicated by prolonged intoxication and residual neurological deficits
-
Craig S: Phenytoin overdose complicated by prolonged intoxication and residual neurological deficits. Emerg Med Australas, 2004; 16: 361-65
-
(2004)
Emerg Med Australas
, vol.16
, pp. 361-365
-
-
Craig, S.1
|